Index Entries - Covid Index

1616 Results

Title	IS Publication Date
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen	June 12, 2020
Ivermectin: an award-winning drug with expected antiviral activity against COVID-19	October 7, 2020
Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectations	February 15, 2017
Ivermectin: Provide partial monitoring results in expanded use in positive patients	June 9, 2021
Jab Injuries Australia
Japanese Professor Upends Ministry of Health: Disband Vax Committee, Investigate All Injuries	December 1, 2022
Jeffrey Sachs on COVID-19 – “I’m pretty convinced it came out of US lab biotechnology"	June 2022
Johnson & Johnson clinical trial: A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants	First posted August 10, 2020; last update May 6, 2023
Kansas AG sues Pfizer for misleading Kansans on COVID vaccine	June 17, 2024
Kids and Speech Delays	January 26, 2022
King County, WA: COVID-19 Outcomes by Vaccination Status
Kolaviron (Kolaflavanone), apigenin, fisetin as potential Coronavirus inhibitors: In silico investigation	August 4, 2020
Kounis syndrome following COVID-19 vaccination: Clinical manifestations, mechanisms and management	June 19, 2024
Laboratory testing for coronavirus disease (COVID-19) in suspected human cases	March 19, 2020
Lack of correlation between school mask mandates and paediatric COVID-19 cases in a large cohort	November 29, 2022
Large-scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection	December 31, 2021
Lasting immunity found after recovery from COVID-19	January 26, 2021
Latest statistics on England mortality data suggest systematic mis-categorisation of vaccine status and uncertain effectiveness of Covid-19 vaccination	December 3, 2021
Legal Letter on Behalf of Physicians Regarding Covid-19 Vaccine Injuries (to heads of the DHHS, CDC, and FDA)	October 27, 2021
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)	February 22, 2021
Lessons Learned from FEMA’s Initial Response to COVID-19	September 21, 2021
Letter from a Los Angeles Psychiatrist to his Patients	February 2022
Letter from Ron Johnson to HHS, FDA and CDC directing them to preserve all records relating to COVID-19 vaccines	November 19, 2024
Letter from Senator Ron Johnson to Lloyd J. Austin III, Secretary of the Department of Defense	February 1, 2022
Letter from US Senators to USAID regarding funding and activities of EcoHealth Alliance	September 14, 2022
Letter of inquiry from the US House Committee on Oversight and Reform to Dr. Kristian Andersen	February 3, 2022
Letter to the Chief Executive of the UK Medicines and Healthcare Products Regulatory Agency: Urgent preliminary report of Yellow Card data up to 26th May 2021	June 9, 2021
Letter to the Editor: Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?	August 9, 2021
Letter to the Editor: Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies	November 5, 2024
Letter to the Editor: Meta-analysis on facemask use in community settings to prevent respiratory infection transmission shows no effect	November 16, 2020
Letter to the Editor: Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden	February 18, 2021
Letter to the Editor: Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination	April 22, 2021
Letter to the Editor: Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections	November 24, 2021
Letter to U.S. Food and Drug Administration, Vaccines and Related Biological Products Advisory Committee in response to “Request for Comments related to consideration of vaccines against SARS-CoV-2”	December 8, 2020
Letter: A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia	April 28, 2020
Letter: Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19	February 18, 2021
Letter: The epidemiological relevance of the COVID-19-vaccinated population is increasing	November 19, 2021
Leveraging epidemiological principles to evaluate Sweden’s COVID-19 response	November 23, 2020
Limitations of models for guiding policy in the COVID-19 pandemic	June 30, 2022
Live virus neutralisation testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2	August 1, 2021
Lockdown Effects on Sars-CoV-2 Transmission – The evidence from Northern Jutland	January 4, 2021
Lockdown, quarantine measures, and social distancing: Associations with depression, anxiety and distress at the beginning of the COVID-19 pandemic among adults from Germany	September 18, 2020
Lockdowns Do Not Control the Coronavirus: The Evidence	December 19, 2020
Long Term Follow-Up After Administration of Human Gene Therapy Products Guidance for Industry	January 2020
Long-COVID Prevalence and Its Association with Health Outcomes in the Post-Vaccine and Antiviral-Availability Era	February 21, 2024
Long-lasting, biochemically modified mRNA, and its frameshifted recombinant spike proteins in human tissues and circulation after COVID-19 vaccination	June 12, 2024
Long-term risk of autoimmune diseases after mRNA-based SARS-CoV2 vaccination in a Korean, nationwide, population-based cohort study	July 23, 2024
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells	July 14, 2021
Longitudinal Trends in Body Mass Index Before and During the COVID-19 Pandemic Among Persons Aged 2–19 Years — United States, 2018–2020	September 17, 2021
Longitudinally extensive transverse myelitis after Covid-19 vaccination: case report and review of literature	March 3, 2022

Page 17 of 33